Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study

Canadian Journal of Urology

Volumn 24, Issue 3, 2017, Pages 8802-8813

  Roehrborn, Claus G ^a   Barkin, Jack ^b   Gange, Steven N ^c   Shore, Neal D ^d   Giddens, Jonathan L ^e   Bolton, Damien M ^f   Cowan, Barrett E ^g   Cantwell, Anthony L ^h   McVary, Kevin T ⁱ   Te, Alexis E ^j   Gholami, Shahram S ^k   Moseley, William G ^l   Chin, Peter T ^m   Dowling, William T ⁿ   Freedman, Sheldon J ^o   Incze, Peter F ^p   Coffield, K Scott ^q   Herron, Sean ^r   Rashid, Prem ^s   Rukstalis, Daniel B ^t  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Toronto Urology Clinical Study Group   (Canada)

^c Summit Urology Group   (United States)

^d Carolina Urologic Research Center   (United States)

^e Jonathan Giddens Medicine Professional Corporation   (Canada)

^f AUSTIN HEALTH   (Australia)

^g Urology Associates of Denver   (United States)

^h Advanced Urology Institute   (United States)

ⁱ SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j WEILL CORNELL MEDICAL COLLEGE   (United States)

^k Pediatric Orthopaedics Associates of Silicon Valley   (United States)

^l Premier Urology Associates   (United States)

^m Illawarra Urology   (Australia)

ⁿ Chesapeake Urology Associates   (United States)

^o Sheldon J Freedman MD Ltd   (United States)

^p The Fe Male Health Centres   (Canada)

^q SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^r Pinellas Urology   (United States)

^s Urology Centre   (Australia)

^t WAKE FOREST BAPTIST HEALTH   (United States)

more..

Author keywords

BPH; Minimally invasive; Sexual function; Surgery; Surgical therapy

Indexed keywords

CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EJACULATION; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PENIS ERECTION; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATISM; PROSTHESES AND ORTHOSES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SEVERITY OF ILLNESS INDEX; SEXUALITY; TREATMENT OUTCOME; URODYNAMICS;

DOUBLE-BLIND METHOD; EJACULATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; PENILE ERECTION; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATISM; PROSTHESES AND IMPLANTS; QUALITY OF LIFE; REOPERATION; SEVERITY OF ILLNESS INDEX; SEXUALITY; TREATMENT OUTCOME; URODYNAMICS;

EID: 85021225450     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)-focus on the UK. BJU Int 2015; 115(4):508-519
2. Berry, SJ, Coffey, DS, Walsh, PC, Ewing, LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132(3): 474-479
3. Cindolo L, Pirozzi L, Fanizza C et al. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol 2015;68(3):418-425
4. Verhamme K, Dieleman J, Bleumink G, Bosch J, Stricker B, Sturkenboom M. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol 2003;44(5):539-545
5. Roehrborn C, McConnell J, Barry M et al. American Urological Association Guideline: Management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research Inc. 2003
6. Reich O, Gratzke C, Bachmann A et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008; 180(1):246-249
7. Flanigan RC, Reda DJ, Wasson JH, Anderson RJ, Abdellatif W, Bruskewitz RC. Five-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol 1998;160(1):12-17
8. Tubaro A, Carter S, Trucchi A, Punzo G, Petta S, Miano L. Early treatment of benign prostatic hyperplasia. Drugs Aging 2003;20(3):185-195
9. Gravas S, Laguna P, Ehrnebo M, Wagrell L, Mattiasson A, de la Rosette JJ. Seeking evidence that cell kill guided thermotherapy gives results not inferior to those of transurethral resection: results of a pooled analysis of 3 studies of feedback transurethral microwave thermotherapy. J Urol 2005;174(3):1002-1006
10. Albala DM, Fulmer BR, Turk TMT et al. Office-based transurethral microwave therapy using the TherMatrx TMX-2000. J Endourol 2002;16(1):57-61
11. Roehrborn CG, Gange SN, Shore ND et al. Multi-Center randomized controlled blinded study of the prostatic urethral lift for the treatment of LUTS associated with prostate enlargement due to BPH: the L.I.F.T. study. J Urol 2013;190(6):2161-2167
12. Shore N, Freedman S, Gange S et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol 2014;21(1):7094-7101
13. McVary KT, Gange SN, Shore ND et al. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of the prostatic urethral lift. J Sex Med 2014;11(1): 279-287
14. Sønksen J, Barber NJ, Speakman M et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 2015;68(4);643-652
15. Cantwell AL, Bogache WK, Richardson SF et al. Multi-Center prospective crossover study of the prostatic urethral lift for the treatment of LUTS secondary to BPH. BJU Int 2013;113(4): 615-622
16. McNicholas TA, Woo HH, Chin PT et al. Minimally invasive prostatic urethral lift: surgical technique and multinational study. Eur Urol 2013;64(2):292-299
17. Chin PT, Bolton DM, Rashid JG et al. Prostatic urethral lift: Twoyear results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia. Urology 2012;79(1):5-11
18. Rukstalis D, Rashid P, Bogache W et al. 24-month durability after crossover to the prostatic urethral lift from randomized, blinded sham. BJU Int 2016;118(Suppl 3):14-22
19. Grino P, Bruskewitz R, Blaivis J et al. Maximum urinary flow rate by uroflowmetry: automatic or visual interpretation. J Urol 1993;149(2):339-341
20. Roehrborn C, Wilson T, Black L. Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the combat trial. J Urol 2012;187(5):1732-1738
21. Miller PD, Kastner C, Ramsey EW, Parsons K. Cooled thermotherapy for the treatment of benign prostatic hyperplasia: durability of results obtained with the Targis system. Urology 2003;61(6):1160-1165
22. Hill B, Belville W, Bruskewitz R et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004;171 (6 Pt 1):2336-2340
23. Liu Z, Li YW, Wu WR, Lu Q. Long-term clinical efficacy and safety profile of transurethral resection of prostate versus plasmakinetic resection of the prostate for benign prostatic hyperplasia. Urology 2017;103:198-203
24. Yamada Y, Furusawa J, Sugimura Y, Kuromatsu I. Photoselective vaporization of the prostate: long-term outcomes and safety during 10 years of follow-up. J Endourol 2016;30(12):1306-1311
25. Hai MA. Photoselective vaporization of prostate: fiveyear outcomes of entire clinic patient population. Urology 2009;73(4):807-810
26. Malde S, Rajagopalan A, Patel N, Simoes A, Choi W, Shrotri N. Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. J Endourol 2012;26(7):878-883
27. Mynderse LA, Roehrborn CG, Partin AW, Preminger GM, Cote EP. Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol 2011;185(5):1804-1810
28. Zlotta AR, Giannakopoulos X, Maehlum O, Ostrem T, Schulman CC. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol 2003;44(1):89-93
29. McConnell JD, Roehrborn CG, Bautista OM et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349(25):2387-2398
30. Narayan P, Evans CP, Moon T. Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. J Urol 2003;170 (2 Pt 1):498-502
31. Lukacs B, Cornu J-N, Aout M et al. Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in France: a comprehensive population study. Eur Urol 2013;64(3):493-501
32. Madersbacher S, Lackner J, Brossner C et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 2005;47(4):499-504
33. Bouza C, Lopez T, Magro A et al. Systematic review and metaanalysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia. BMC Urol 2006;6:14
34. Hoffman RM, Monga M, Elliott SP et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev 2012;9: CD004135
35. Kawabe K, Homma Y, Kubota K, Sozu T. How frequent are invasive therapies required in patients receiving tamsulosin for benign prostatic hyperplasia? A retrospective long-term study. Int J Urol 2006;13(2):127-131
36. Masumori N, Hashimoto J, Itoh N, Tsukamoto T. Short-term efficacy and long-term compliance/treatment failure of the a1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Scand J Urol Nephrol 2007;41(5):422-429
37. McConnell JD, Bruskewitz R, Walsh P et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 1998;338(9):557-563
38. Kim CI, Chang HS, Kim BK, Park CH. Long-term results of medical treatment in benign prostatic hyperplasia. Urology 2006;68(5): 1015-1019
39. Issa MM, Lin PJ, Eaddy MT, Shah MB, Davis EA. Comparative analysis of alpha-blocker utilization in combination with 5-alpha reductase inhibitors for enlarged prostate in managed care setting among Medicare-aged men. Am J Manag Care 2008;14(5 Suppl 2): S160-S166
40. Strope SA, Vetter J, Elliott S, Andriole GL, Olsen MA. Use of medical therapy and success of laser surgery and transurethral resection of the prostate for benign prostatic hyperplasia. Urology 2015;86(6):1115-1122